SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-24-000032
Filing Date
2024-05-14
Accepted
2024-05-14 17:04:16
Documents
78
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alim-20240331x10q.htm   iXBRL 10-Q 3337672
2 EX-10.4 alim-20240331xex10_4.htm EX-10.4 329998
3 EX-31.1 alim-20240331xex31_1.htm EX-31.1 21005
4 EX-31.2 alim-20240331xex31_2.htm EX-31.2 21272
5 EX-32.1 alim-20240331xex32_1.htm EX-32.1 16036
  Complete submission text file 0001267602-24-000032.txt   12793222

Data Files

Seq Description Document Type Size
6 EX-101.SCH alim-20240331.xsd EX-101.SCH 55249
7 EX-101.CAL alim-20240331_cal.xml EX-101.CAL 67626
8 EX-101.DEF alim-20240331_def.xml EX-101.DEF 240431
9 EX-101.LAB alim-20240331_lab.xml EX-101.LAB 557798
10 EX-101.PRE alim-20240331_pre.xml EX-101.PRE 440206
82 EXTRACTED XBRL INSTANCE DOCUMENT alim-20240331x10q_htm.xml XML 2738356
Mailing Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005
Business Address 6310 TOWN SQUARE SUITE 400 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 24945552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)